Data

Amal Therapeutics amplifies series B round
Boehringer Ingelheim and Helsinn helped oncology vaccine developer Amal reach the second close of a series B round that now totals $32.7m.
Dealflow continues to grow in October
This is our data snapshot based on last month’s investment activity. The charts and tables have been generated by our data platform GCV Analytics.
Finance finds the way forward
GCV Analytics defines the financial services sector as encompassing payment technologies and cryptocurrencies, personal finance and wealth management, insurance, alternative lending, crowdfunding, client and risk analytics, firms and funds, social investing and others.
Analysis: CVC-backed deals as part of the entire VC realm
In this short piece, we provide a comparison of our GCV Analytics data with Pitchbook’s data up until the end of the third quarter of 2018.
Analysis: Grab books $200m
Travel and accommodation booking service Booking Holdings committed $200m to ride hailing app Grab alongside a partnership deal
Dealflow maintains pace in September
This is our data snapshot based on last month’s investment activity. 
The charts and tables have been generated by our data platform GCV Analytics.
The challenge of battery tech investment
A range of new materials and technologies could yield vastly improved batteries for purposes including electric vehicles and grid storage.
Energy sector grows again
Sector report: Energy

News Continued

Strong third quarter for corporate venturing
The following is a snapshot of the data we have collected on investment activity over the past three months. To verify reported deals, we contact about 300 corporate investors each quarter – these comprise roughly 18% of the global CVCs we cover, but account for most of the deals that are made public.
Tencent thrives on value in its portfolio companies
Company profile: Tencent
Deal temperature rises in July and August
Analysis: Toyota adds $500m to Uber
Uber has struck a strategic partnership on autonomous car research with Toyota, which featured a $500m investment from the auto manufacturer at a $72bn valuation.
Analysis: Orchard raises $150m for gene therapies
Two corporate players backed gene therapeutics firm Orchard Therapeutics in a round that may indicate an uptick in investments in genetics-related tech for this year
Analysis: Uptick in e-commerce last week
Last week, Global Corporate Venturing reported several interesting and sizeable transactions in the e-commerce space from around the globe.

Editor's Picks

Analysis: CVC-backed deals as part of the entire VC realm
In this short piece, we provide a comparison of our GCV Analytics data with Pitchbook’s data up until the end of the third quarter of 2018.
Analysis: 23andMe raises $250m
Genetics services company 23andMe, previously backed by Alphabet, Illumina, WuXi PharmaTech and Johnson and Johnson, secured a large $250m round.
Corporate venturing boom era breakdown
GCV Analytics provides an in-depth breakdown of corporate venturing activity during the boom period of corporate venturing.
China, Asia tech giants turn heads in Q2
2015 Q2 Report
test reg

Login